JP2004525940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004525940A5 JP2004525940A5 JP2002576957A JP2002576957A JP2004525940A5 JP 2004525940 A5 JP2004525940 A5 JP 2004525940A5 JP 2002576957 A JP2002576957 A JP 2002576957A JP 2002576957 A JP2002576957 A JP 2002576957A JP 2004525940 A5 JP2004525940 A5 JP 2004525940A5
- Authority
- JP
- Japan
- Prior art keywords
- duloxetine
- use according
- raloxifene
- hot flashes
- estrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ZEUITGRIYCTCEM-KRWDZBQOSA-N (S)-duloxetine Chemical compound C1([C@@H](OC=2C3=CC=CC=C3C=CC=2)CCNC)=CC=CS1 ZEUITGRIYCTCEM-KRWDZBQOSA-N 0.000 claims 13
- 229960002866 duloxetine Drugs 0.000 claims 13
- 208000033830 Hot Flashes Diseases 0.000 claims 6
- 206010060800 Hot flush Diseases 0.000 claims 6
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 claims 5
- 229960004622 raloxifene Drugs 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 229940011871 estrogen Drugs 0.000 claims 3
- 239000000262 estrogen Substances 0.000 claims 3
- 238000009164 estrogen replacement therapy Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 229960002119 raloxifene hydrochloride Drugs 0.000 claims 1
- BKXVVCILCIUCLG-UHFFFAOYSA-N raloxifene hydrochloride Chemical group [H+].[Cl-].C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 BKXVVCILCIUCLG-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27989601P | 2001-03-29 | 2001-03-29 | |
| US34808402P | 2002-01-11 | 2002-01-11 | |
| PCT/US2002/005113 WO2002078691A1 (en) | 2001-03-29 | 2002-03-15 | Duloxetine for treatment of hot flashes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004525940A JP2004525940A (ja) | 2004-08-26 |
| JP2004525940A5 true JP2004525940A5 (cg-RX-API-DMAC7.html) | 2005-12-22 |
Family
ID=26959949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002576957A Pending JP2004525940A (ja) | 2001-03-29 | 2002-03-15 | 火照りの処置のためのデュロキセチン |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1383495A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004525940A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2442410A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002078691A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050049476A (ko) * | 2002-08-14 | 2005-05-25 | 파마시아 앤드 업존 캄파니 엘엘씨 | 홍조를 치료하기 위한 레복세틴의 용도 |
| US20040152710A1 (en) * | 2002-10-15 | 2004-08-05 | Deecher Darlene Coleman | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| US7491723B2 (en) | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
| US7524846B2 (en) | 2003-10-14 | 2009-04-28 | Wyeth | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| US7531543B2 (en) | 2003-10-14 | 2009-05-12 | Wyeth | Phenylpiperazine cycloalkanol derivatives and methods of their use |
| US7402698B2 (en) | 2003-10-14 | 2008-07-22 | Wyeth | Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use |
| US7550485B2 (en) | 2003-10-14 | 2009-06-23 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
| US7365076B2 (en) | 2003-10-14 | 2008-04-29 | Wyeth | Substituted aryl cycloalkanol derivatives and methods of their use |
| US7419980B2 (en) | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
| DE602004014823D1 (de) * | 2003-12-12 | 2008-08-14 | Lilly Co Eli | Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen |
| US7517899B2 (en) | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7414052B2 (en) | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| JP2008543929A (ja) * | 2005-06-20 | 2008-12-04 | カディラ・ヘルスケア・リミテッド | デュロキセチンの調節放出型の投与製剤 |
| SG11201708162UA (en) * | 2015-04-07 | 2017-11-29 | Meiji Co Ltd | Hot flash-suppressing agent |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508276A (en) * | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
| CZ287798A3 (cs) * | 1996-03-11 | 1999-05-12 | Eli Lilly And Company | Použití duloxetinu pro výrobu léčiva, duloxetin k použití v léčbě nebo prevenci a farmaceutický přípravek s jeho obsahem |
| BR9908431A (pt) * | 1998-03-02 | 2000-10-31 | Lilly Co Eli | Cloridrato de fluoxetina para diminuição de fogalhos |
-
2002
- 2002-03-15 EP EP02707828A patent/EP1383495A1/en not_active Withdrawn
- 2002-03-15 CA CA002442410A patent/CA2442410A1/en not_active Abandoned
- 2002-03-15 WO PCT/US2002/005113 patent/WO2002078691A1/en not_active Ceased
- 2002-03-15 JP JP2002576957A patent/JP2004525940A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004525940A5 (cg-RX-API-DMAC7.html) | ||
| JP2017057230A5 (cg-RX-API-DMAC7.html) | ||
| JP2005515966A5 (cg-RX-API-DMAC7.html) | ||
| JP2015524444A5 (cg-RX-API-DMAC7.html) | ||
| JP2005512995A5 (cg-RX-API-DMAC7.html) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2006522006A5 (cg-RX-API-DMAC7.html) | ||
| JP2002502871A5 (cg-RX-API-DMAC7.html) | ||
| NO20014519L (no) | Apomorfin- og sildenafilpreparat | |
| ATE339954T1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| MY126555A (en) | Oral pharmaceutical extended release dosage form | |
| JP2010502762A5 (cg-RX-API-DMAC7.html) | ||
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| JP2005508955A5 (cg-RX-API-DMAC7.html) | ||
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| ME02474B (me) | Terapijski režimi | |
| JP2005508963A5 (cg-RX-API-DMAC7.html) | ||
| TNSN07474A1 (en) | Dosage regimen for prasugrel | |
| JP2009500045A5 (cg-RX-API-DMAC7.html) | ||
| JP2002540148A5 (cg-RX-API-DMAC7.html) | ||
| RU2005135647A (ru) | Комбинации, включающие пароксетин и {1-(r)-(3.5-бис-трифтор-2-метилфенил) этилметиламид}-2-(s)-(4-фтор-2-метилфенил) пиперазин-1-карбоновой кислоты, для лечения депрессии и/или тревоги | |
| JP2003523385A5 (cg-RX-API-DMAC7.html) | ||
| JP2010524906A5 (cg-RX-API-DMAC7.html) | ||
| JP2005503391A5 (cg-RX-API-DMAC7.html) | ||
| JP2001316293A5 (cg-RX-API-DMAC7.html) |